ALOX5 and Alzheimer disease: Comparing the conversion of 17-HDHA to RvD3, which is also mediated by 5-LOX, similar trends were observed where female APOE4 carriers with AD displayed the greatest RvD3: 17-HDHA metabolite ratios compared to their NCI control group (>5-fold increase).